当前位置:首页 - 行情中心 - 西藏药业(600211) - 财务分析

西藏药业

(600211)

  

流通市值:113.01亿  总市值:113.01亿
流通股本:3.22亿   总股本:3.22亿

西藏药业(600211)财务分析

净利润 + 每股收益
Created with Highcharts 9.1.012-3109-3006-3003-310481201.63.24.8
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润10.57亿元,每股收益3.26元。

股东权益 + 未分配利润
Created with Highcharts 9.1.012-3109-3006-3003-31015304519202122
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益395210.51万元,未分配利润216651.48万元。

总资产 + 负债
Created with Highcharts 9.1.012-3109-3006-3003-3102040606121824
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产474733.83万元,负债79523.32万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入2,806,713,295.852,175,443,351.591,614,697,734.98704,221,182.53
营业总成本1,865,690,7891,408,185,831.631,028,685,651.52444,139,520.2
营业利润1,160,450,276.72884,452,957.66697,332,349.66347,266,516.45
利润总额1,152,084,060.44882,826,441.17695,874,085.73347,440,052.38
净利润1,057,075,195.66795,146,775.01626,083,557.68315,241,177.6
其他综合收益16,352,053.8-12,079,404.536,723,909.441,815,542.14
综合收益总额1,073,427,249.46783,073,875.81632,807,467.12317,056,719.74
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计3,569,908,233.163,492,491,291.764,135,022,045.843,916,998,705.03
非流动资产合计1,177,430,107.971,178,542,722.441,200,731,508.971,172,481,531.92
资产总计4,747,338,341.134,671,034,014.25,335,753,554.815,089,480,236.95
流动负债合计766,571,363.98976,373,627.131,478,888,605.521,367,078,135.26
非流动负债合计28,661,867.6230,935,156.5231,716,959.5730,274,669.07
负债合计795,233,231.61,007,308,783.651,510,605,565.091,397,352,804.33
归属于母公司股东权益合计3,917,816,533.713,629,963,702.73,791,719,484.953,659,323,698.64
股东权益合计3,952,105,109.533,663,725,230.553,825,147,989.723,692,127,432.62
负债和股东权益合计4,747,338,341.134,671,034,014.25,335,753,554.815,089,480,236.95
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计3,532,316,583.782,783,019,017.981,917,954,752.41,111,241,958.29
经营活动现金流出小计2,537,525,771.962,035,757,009.531,323,243,483.33675,064,182.48
经营活动产生的现金流量净额994,790,811.82747,262,008.45594,711,269.07436,177,775.81
投资活动现金流入小计4,912,682,591.623,577,250,394.82,284,653,027.271,044,743,172.09
投资活动现金流出小计4,558,196,774.613,406,174,323.242,502,650,902.061,384,328,298.73
投资活动产生的现金流量净额354,485,817.01171,076,071.56-217,997,874.79-339,585,126.64
筹资活动现金流入小计534,947,148.22434,048,862.95433,040,472.24261,566,016.54
筹资活动现金流出小计1,267,939,919.431,050,332,572.98371,704,140.482,289,385.11
筹资活动产生的现金流量净额-732,992,771.21-616,283,710.0361,336,331.76259,276,631.43
汇率变动对现金及现金等价物的影响7,437,746.19-6,913,756.98700,485.122,047,665.48
现金及现金等价物净增加额623,721,603.81295,140,613438,750,211.16357,916,946.08
期末现金及现金等价物余额1,305,901,166.05977,320,175.241,120,929,773.41,040,096,508.32
最新报告期:2025-03-24
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
首创证券王斌3.053.243.572025-03-24
西南证券杜向阳,王彦迪2.923.253.522025-03-17
TOP↑